Telesis Bio, Inc. (TBIO)
Telesis Bio, Inc., formerly known as Codex DNA, Inc. (and SGI-DNA, Inc. prior to that), is a San Diego, California-based synthetic biology company established in 2011. The company provides a comprehensive suite of instruments, reagents, and services for synthetic biology applications, catering primarily to pharmaceutical and academic laboratories worldwide. Its clientele also extends to government institutions, contract research organizations (CROs), and other synthetic biology enterprises. Among its core offerings is the BioXp system, a groundbreaking platform that empowers researchers to generate endpoint-ready synthetic DNA directly from digital sequences. Complementing this, the BioXp portal offers an intuitive online environment with guided workflows and design tools for constructing new DNA sequences and assembling them into desired vectors. For specific synthetic biology tasks, Telesis Bio supplies BioXp kits, which include essential building blocks and proprietary reagents like its well-known Gibson Assembly products. Additional solutions encompass cloud-based scripts and specialized benchtop reagents designed for post-BioXp system workflows. Through its Biofoundry Services, customers can commission and receive BioXp system-generated products, such as custom genes, clones, cell-free amplified DNA, and diverse variant libraries. The company also performs enzymatic DNA synthesis using short oligo ligation assembly techniques.
Sector: Medical - Devices
Industry: Medical - Devices
Telesis Bio, Inc.
- 1:18Reverse splitMay 9, 202418 shares → 1
- 1:30Reverse splitJun 13, 201730 shares → 1
- 1:12Reverse splitJan 28, 201412 shares → 1
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $27.51M | $27.43M | $11.04M | $6.58M | $4.8M | $1.42M | $0 | $0 |
| YoY Growth | 0.3% | 148.4% | 67.9% | 36.9% | 238.4% | - | - | - |
| Cost of Revenue | $10.56M | $11.84M | $6.74M | $2.95M | $8.89M | $0 | $0 | $0 |
| Gross Profit | $16.95M | $15.6M | $4.3M | $3.63M | -$4.08M | $1.42M | $0 | $0 |
| Gross Margin | 61.6% | 56.8% | 38.9% | 55.1% | -85.0% | 100.0% | - | - |
| Research and Development | $17.5M | $23.46M | $14.55M | $8.93M | $1.32M | $58.02M | $47.02M | $15.66M |
| Selling, General, and Administrative | $34.6M | $38.62M | $25.13M | $11.06M | $1.57M | $22.61M | $14.31M | $11.14M |
| Other | $11.39M | $0 | $300K | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $63.49M | $62.08M | $39.67M | $19.99M | $2.89M | $80.63M | $61.33M | $26.8M |
| Operating Income (EBIT) | -$46.54M | -$46.48M | -$35.37M | -$16.36M | -$6.98M | -$102.96M | -$78.92M | -$26.7M |
| Operating Margin | -169.2% | -169.4% | -320.3% | -248.8% | -145.2% | -7250.7% | - | - |
| Interest Expense | $3.1M | $1.96M | $1.37M | $690K | $1.49M | $0 | $0 | $0 |
| Interest Income | $1.74M | $738K | $0 | $0 | $1.79M | $1.32M | $281K | $114K |
| Other Income (Expense) | -$1.16M | -$1.96M | -$3.57M | -$1.64M | -$1.33M | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$47.7M | -$48.45M | -$38.94M | -$18M | -$8.3M | -$102.96M | -$78.92M | -$26.7M |
| Income Tax Expense | $24K | $24K | $14K | $5K | $0 | -$5.57M | -$12.48M | $0 |
| Net Income | -$47.72M | -$48.47M | -$38.96M | -$18.01M | -$8.3M | -$97.39M | -$66.44M | -$26.7M |
| Net Income Margin | -173.5% | -176.7% | -352.8% | -273.9% | -172.8% | -6858.8% | - | - |
| Supplementary Data | ||||||||
| EPS | -1.59 | -1.65 | -1.33 | -0.62 | -0.20 | -2.16 | -2.23 | -0.89 |
| Diluted EPS | -1.59 | -1.65 | -1.33 | -0.62 | -0.20 | -2.16 | -2.23 | -0.89 |
| Weighted Average OS | 29.93M | 29.46M | 29.32M | 29.23M | 40.76M | 45.00M | 29.86M | 29.86M |
| EBITDA | -$40.49M | -$43.62M | -$36M | -$15.86M | -$5.96M | -$100.12M | -$77.34M | -$25.97M |
| EBITDA Margin | -147.2% | -159.0% | -326.0% | -241.1% | -123.9% | -7050.6% | - | - |
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $1.57M | $30.42M | $82.81M | $13.46M | $29.14M | $55.2M | $48.06M | $57.73M |
| Short-Term Investments | $17.59M | $13.16M | $0 | $0 | $0 | $88.9M | $10M | $12.99M |
| Cash and Short-Term Investments | $19.16M | $43.75M | $82.81M | $13.46M | $29.14M | $144.1M | $58.05M | $70.72M |
| Accounts Receivable | $5.99M | $5.85M | $3.67M | $2.27M | $1.49M | $0 | $0 | $0 |
| Inventory | $4.03M | $2.2M | $2.37M | $601K | $712K | $0 | $0 | $0 |
| Other Current Assets | $175K | $3.29M | $4.34M | $0 | $0 | $5.5M | $4.98M | $1.72M |
| Total Current Assets | $30.35M | $55.09M | $93.18M | $17.18M | $31.43M | $149.6M | $63.03M | $72.44M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $34.52M | $8.52M | $5.74M | $3.78M | $888K | $10.24M | $6.78M | $4.86M |
| Goodwill | $3.5M | $14.89M | $14.33M | $3.5M | $3.5M | $21.36M | $21.36M | $21.36M |
| Intangible Assets | $1.37M | $1.88M | $2.4M | $2.33M | $2.86M | $106.44M | $106.84M | $106.84M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $676K | $981K | $609K | $81K | $81K | $0 | $533K | $65K |
| Total Long-Term Assets | $40.06M | $26.27M | $23.07M | $9.68M | $7.33M | $138.05M | $135.51M | $133.13M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $70.41M | $81.36M | $116.26M | $26.86M | $38.76M | $287.65M | $198.55M | $205.56M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $3.28M | $1.29M | $2.5M | $1.19M | $614K | $5.17M | $4.59M | $462K |
| Short-Term Debt | $0 | $0 | $603K | $1.33M | $530K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $338K | $3.96M | $205K | $606K | $112K | $2.57M | $0 | $0 |
| Other Current Liabilities | $92K | $373K | $335K | $22K | -$530K | $6.55M | $7.49M | $11.55M |
| Total Current Liabilities | $8.18M | $13.5M | $9.73M | $5.63M | $1.72M | $14.29M | $12.09M | $12.01M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $5.27M | $19.65M | $14.09M | $3.35M | $4.47M | -$34.58M | $0 | $0 |
| Long-Term Unearned Revenue | $95K | $142K | $150K | $40K | $33K | $41.84M | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $481K | $6.04M | $18.52M |
| Other Long-Term Liabilities | $36K | $367K | $108K | $40.45M | $39.88M | $140.33M | $273.94M | $213.63M |
| Total Long-Term Liabilities | $32.69M | $21.3M | $15.74M | $46.7M | $44.54M | $148.07M | $279.98M | $232.15M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $40.87M | $34.8M | $25.47M | $52.32M | $46.26M | $162.36M | $292.06M | $244.15M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $29.3M | $0 | $0 | $38.91M | $38.91M | $0 | $0 | $0 |
| Common Stock | $5K | $5K | $5K | $2K | $2K | $45K | $10K | $9K |
| Retained Earnings | -$161.47M | -$113.74M | -$65.27M | -$26.31M | -$8.3M | -$246.2M | -$148.81M | -$82.36M |
| Comprehensive Income & Other | $0 | -$3K | $0 | -$38.91M | -$38.91M | $196K | $79K | $0 |
| Other Stockholders' Equity | $191M | $160.3M | $156.05M | $851K | $797K | $371.45M | $55.28M | $43.77M |
| Total Equity | $29.54M | $46.56M | $90.78M | -$25.46M | -$7.5M | $125.3M | -$93.52M | -$38.59M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $70.41M | $81.36M | $116.26M | $26.86M | $38.76M | $287.65M | $198.55M | $205.56M |
| Supplementary Data | ||||||||
| Total Debt | $34.38M | $21.43M | $17.32M | $8.33M | $4.77M | $0 | $0 | $0 |
| Net Debt | $32.81M | -$8.99M | -$65.48M | -$5.14M | -$24.38M | -$55.2M | -$48.06M | -$57.73M |
| Period | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||
| Net Income | -$47.72M | -$48.47M | -$38.96M | -$18.01M | -$8.3M | -$97.39M | -$66.44M | -$26.7M |
| Depreciation & Amortization | $4.1M | $2.88M | $1.57M | $1.46M | $857K | $2.84M | $1.58M | $730K |
| Deferred Income Tax | $0 | $0 | $2.3M | $443K | -$486K | -$5.57M | -$12.48M | $0 |
| Stock-Based Compensation | $3.96M | $3.73M | $1.09M | $43K | $13K | $0 | $3.68M | $686K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | -$1.33M | -$2.19M | -$735K | -$774K | -$859K | $0 | $0 | $0 |
| Inventory | -$1.82M | $168K | -$1.46M | $111K | $723K | $0 | $0 | $0 |
| Accounts Payable | -$3.29M | $1.16M | -$298K | $142K | $232K | $658K | $4.03M | $84K |
| Other Working Capital | -$1.32M | $2.98M | -$542K | $501K | $129K | $83.71M | -$13.51M | $980K |
| Total Working Capital Change | -$7.77M | $2.13M | -$3.04M | -$20K | $225K | $84.36M | -$9.48M | $1.06M |
| Other Non-Cash Items | $12.76M | $1.02M | $333K | $706K | $1.3M | -$13.71M | $32.35M | $500K |
| Net Cash from Operating | -$34.67M | -$38.72M | -$36.7M | -$15.38M | -$6.39M | -$22.13M | -$50.79M | -$23.72M |
| Investing Activities | ||||||||
| Capital Expenditures | -$1.98M | -$4.47M | -$1.85M | -$204K | -$79K | -$6.58M | -$2.77M | -$862K |
| Acquisitions | $16K | -$556K | -$13.19M | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$33.77M | -$77.43M | $0 | $0 | -$174.27M | -$136.69M | -$70.77M | -$34.93M |
| Sales of Investments | $30M | $64.44M | $0 | $0 | $159.62M | $57.98M | $73.84M | $41.9M |
| Other Investing Activities | $0 | $0 | $0 | $0 | $14.65M | $0 | $0 | $0 |
| Net Cash from Investing | -$5.74M | -$18.01M | -$15.04M | -$204K | -$79K | -$85.29M | $304K | $6.11M |
| Financing Activities | ||||||||
| Debt Repaid | $15.09M | -$4.68M | -$9.79M | $107K | - | - | - | - |
| Common Stock Issuance | $26.66M | $528K | $112.48M | $11K | $32.95M | $117.45M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $8.25M | -$700K | -$1.19M | $0 | $35.11M | $113.62M | $41.75M | $50.75M |
| Net Cash from Financing | $11.56M | $4.51M | $121.08M | -$96K | $35.11M | $113.62M | $41.75M | $50.75M |
| Forex Effect | -$3K | $0 | $0 | $0 | $669K | $0 | $0 | $0 |
| Net Change in Cash | -$28.85M | -$52.21M | $69.34M | -$15.68M | -$27.08M | $6.2M | -$8.74M | $33.14M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$34.67M | -$38.72M | -$36.7M | -$15.38M | -$6.39M | -$22.13M | -$50.79M | -$23.72M |
| Capital Expenditure | -$1.98M | -$4.47M | -$1.85M | -$204K | -$79K | -$6.58M | -$2.77M | -$862K |
| Free Cash Flow | -$36.65M | -$43.18M | -$38.55M | -$15.59M | -$6.47M | -$28.71M | -$53.56M | -$24.58M |
| Cash at Beginning | $30.59M | $82.81M | $13.46M | $29.14M | $56.22M | $50.02M | $58.76M | $25.62M |
| Cash at End | $1.75M | $30.59M | $82.81M | $13.46M | $29.14M | $56.22M | $50.02M | $58.76M |